Deborah Knobelman, President & Interim CEO at Kronos Bio, Inc. (KRON), sold 24,838 shares at $0.87 ($22K) on 2025-06-05, disclosed to the SEC on 2025-06-06.
Open-market sale of $22k KRON by President & Interim CEO. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Something here stands out, but not much.